ADGRL2 and cancer: As the fold change threshold increased (>3.0), the number of differentially expressed genes decreased, but core regulatory genes such as ADGRL2, NR2F1, S100A16, and KRT19 remained consistently altered, highlighting isoform-specific regulation of key cancer-associated genes.